Publications by authors named "Stefano Capri"

Claim this Profile
A
A New Health Networking Infrastructure on Cancer Is Taking Shape in Europe: A Not-to-Miss Opportunity for the EU Regulatory System.
Paolo Giovanni Casali, Stefano Capri

J Mark Access Health Policy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy.
Elaine Julian, Tom Belleman, Maria João Garcia, Maureen Rutten-van Mölken, Robin Doeswijk, Stefano Capri

J Mark Access Health Policy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valuation of Medical Innovation Handling with Uncertainty and Risk.
Mark Nuijten, Stefano Capri

J Mark Access Health Policy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for sickle cell disease: focus on newborn investigations.
Andrea Mosca, Renata Paleari, Giovanni Palazzi, Alessia Pancaldi, Lorenzo Iughetti, Stefano Capri

Clin Chem Lab Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators.
Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven Simoens, Stefano Capri

J Mark Access Health Policy· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of stakeholder involvement in the evolving EU HTA process: .
Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet, Walter Van Dyck, Steven Simoens, Stefano Capri

J Mark Access Health Policy· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments.
Andrea Aiello, Elisa Elena Mariano, Mariangela Prada, Cristina Teruzzi, Nicoletta Martone, Stefano Capri

J Mark Access Health Policy· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach.
Stefano Capri, Fernando Antoñanzas, Rosella Levaggi

Expert Rev Pharmacoecon Outcomes Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs.
Alessandra Romandini, Damiano Baldassarre, Stefano Genovese, Stefano Capri, Giulio Pompilio

Pharmaceuticals (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated valuation model for payer and investor.
Mark Nuijten, Stefano Capri

J Mark Access Health Policy· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life study.
Maria Manara, Roberto Caporali, Claudia Lomater, Roberto Gorla, Enrico Fusaro, Stefano Capri

Clin Exp Rheumatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficiency ratio and rocketing drug prices: old concerns and new possibilities.
Stefano Capri, Fernando Antonanzas

Eur J Health Econ· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An updated cost-effectiveness analysis of pazopanib versus sunitinib as first-line treatment for locally advanced or metastatic renal cell carcinoma in Italy.
Stefano Capri, Camillo Porta, Claudia Condorelli, Eleonora Premoli, Ankur Khare

J Med Econ· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pricing of orphan drugs in oncology and rare diseases.
Mark Nuijten, Stefano Capri

J Mark Access Health Policy· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-effectiveness and budget impact analysis of apremilast in patients with psoriatic arthritis in Italy.
Stefano Capri, A Migliore, F Loconsole, Marco Barbieri

J Med Econ· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment.
Chiara de Waure, Sara Boccalini, Paolo Bonanni, Daniela Amicizia, Andrea Poscia, Stefano Capri

Eur J Public Health· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population.
Stefano Capri, Marco Barbieri, Chiara de Waure, Sara Boccalini, Donatella Panatto

Hum Vaccin Immunother· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaches to manage 'affordability' of high budget impact medicines in key EU countries.
Mathias Flume, Marc Bardou, Stefano Capri, Oriol Sola-Morales, David Cunningham

J Mark Access Health Policy· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DEFINING INNOVATION WITH RESPECT TO NEW MEDICINES: A SYSTEMATIC REVIEW FROM A PAYER PERSPECTIVE.
Oriol de Solà-Morales, David Cunningham, Mathias Flume, Paul M Overton, Natalie Shalet, Stefano Capri

Int J Technol Assess Health Care· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethical Hurdles in the Prioritization of Oncology Care.
Folkert de Groot, Stefano Capri, Jean-Claude Castanier, David Cunningham, Bruno Flamion

Appl Health Econ Health Policy· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Pazopanib Versus Sunitinib as First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma from an Italian National Health Service Perspective.
Stefano Capri, Camillo Porta, Thomas E Delea

Clin Ther· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of breast cancer based on real-world data: a cancer registry study in Italy.
Stefano Capri, Antonio Russo

BMC Health Serv Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and attractiveness of indication value-based pricing in key EU countries.
Mathias Flume, Marc Bardou, Stefano Capri, Oriol Sola-Morales, David Cunningham

J Mark Access Health Policy· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracorporeal Photopheresis for Second-Line Treatment of Chronic Graft-versus-Host Diseases: Results from a Health Technology Assessment in Italy.
Chiara de Waure, Stefano Capri, Maria Assunta Veneziano, Maria Lucia Specchia, Chiara Cadeddu

Value Health· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of adult obesity on health systems: a systematic review.
Maria Lucia Specchia, Maria Assunta Veneziano, Chiara Cadeddu, Anna Maria Ferriero, Agostino Mancuso, Stefano Capri

Eur J Public Health· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis